Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank86
3Y CAGR+62.4%
5Y CAGR+37.8%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+62.4%/yr
vs +6.5%/yr prior
5Y CAGR
+37.8%/yr
Recent acceleration
Acceleration
+56.0pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
5x
Strong expansion
Streak
2 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.83 | -6.4% |
| 2024 | 0.89 | -8.9% |
| 2023 | 0.98 | +402.6% |
| 2022 | 0.19 | -17.4% |
| 2021 | 0.23 | +40.5% |
| 2020 | 0.17 | -4.3% |
| 2019 | 0.17 | +15.7% |
| 2018 | 0.15 | +8.1% |
| 2017 | 0.14 | +22.0% |
| 2016 | 0.11 | - |